文献速递头颈部肿瘤放疗泌尿生殖与妇科肿瘤放疗放疗物理与技术

加泰罗尼亚癌症患者放疗不依从对1年生存的影响

Impact of non-adherence to radiotherapy on 1-year survival in cancer patients in Catalonia, Spain.
PubMed 文献 · Radiother Oncol · 2020-08-06

该回顾性队列研究纳入2016年西班牙加泰罗尼亚地区8721例接受根治性外照射放疗的癌症患者,以接受至少90%处方总剂量定义为依从。结果显示不依从率仅1.0%,不依从者1年死亡风险高于依从者(HR 1.63,95%CI 0.97-2.74)。

要点

  • 不依从定义为接受剂量不足处方总剂量的90%,本队列不依从率仅1.0%。
  • 不依从与高龄、女性及头颈、膀胱、血液系统肿瘤部位相关。
  • 校正年龄、性别、肿瘤部位和合并症后,不依从者死亡风险HR为1.63(95%CI 0.97-2.74)。

核心结论

  • 在接受根治性外照射放疗的癌症患者中,以接受剂量衡量的放疗不依从率很低,但可能影响1年生存。

研究设计与样本

  • 西班牙加泰罗尼亚地区2016年所有接受根治性外照射放疗癌症患者的回顾性队列研究,最终样本8721例,平均年龄63.6岁。

主要发现

  • 乳腺癌为最常见瘤种(38.1%),其次为前列腺癌和结肠/直肠癌。
  • 70.7%的患者因治疗中断而延长总疗程,1.0%的患者不依从。
  • 不依从与高龄、女性及头颈、膀胱和血液系统肿瘤部位相关。
  • 校正年龄、性别、肿瘤部位和合并症后,不依从者死亡风险高于依从者(HR 1.63,95%CI 0.97-2.74)。

关键数值与推荐

  • 依从定义为接受至少90%的处方总剂量。

临床怎么用

  • 对高龄、女性及头颈、膀胱、血液系统肿瘤患者应关注放疗依从性,减少治疗中断以保障足量照射。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aims to assess the effects of non-adherence to external beam radiation therapy in cancer patients receiving treatment with a curative. METHODS: This retrospective cohort study collected health records data for all cancer patients treated with external beam radiotherapy with curative intent in 2016 in Catalonia, Spain. Adherence was defined as having received at least 90% of the total dose prescribed. A logistic regression model was used to assess factors related to non-adherence, and its association with one-year survival was evaluated using Cox regression. RESULTS: The final sample included 8721 patients (mean age 63.6 years): breast cancer was the most common tumour site (38.1%), followed by prostate and colon/rectum. Treatment interruptions prolonged the total duration of therapy in 70.7% of the patients, and 1.0% were non-adherent. Non-adherence was associated with advanced age, female gender, and some localization of primary tumour (head and neck, urinary bladder, and haematological cancers). The risk of death in non-adherent patients was higher than in adherent patients (hazard ratio [HR] 1.63, 95% confidence interval 0.97-2.74), after adjusting for the potential confounding effect of age, gender, tumour site and comorbidity. CONCLUSION: Non-adherence to radiotherapy, as measured by the received dose, is very low in our setting, and it may have an impact on one-year survival.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Borras JM, Font R, Solà J, et al. Impact of non-adherence to radiotherapy on 1-year survival in cancer patients in Catalonia, Spain. Radiother Oncol. 2020. PMID: 32771615. doi:10.1016/j.radonc.2020.08.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。